This compound is a phosphoramidite-modified purine nucleoside derivative used as an oligonucleotide building block intermediate. It features a protected guanine base and a morpholino ring system with a trityl protecting group, enabling selective incorporation into synthetic oligonucleotide chains.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 956139-25-6
N-[9-[(2R,6S)-6-[[chloro(dimethylamino)phosphoryl]oxymethyl]-4-tritylmorpholin-2-yl]-6-oxo-1H-purin-2-yl]-2-phenylacetamide
Pharmaceutical intermediate for oligonucleotide synthesis
(6-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-tritylmorpholin-2-yl)methyl dimethylphosphoramidochloridate)
Phosphoramidate monomer for oligonucleotide synthesis
5-Methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid
Pharmaceutical intermediate for suvorexant
Thymidine 5'-diphosphoric acid trisodium salt
nucleotide diphosphate intermediate
6-chloro-2-methoxypyridine-3-carbaldehyde
Pharmaceutical intermediate synthesis
N-[9-[(2R,6S)-6-[[chloro(dimethylamino)phosphoryl]oxymethyl]-4-tritylmorpholin-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide
JEXKEVAZWLLEBW-OXJZQVEGSA-N
CC(C)C(=O)NC1=NC2=C(C(=O)N1)N=CN2[C@H]3CN(C[C@H](O3)COP(=O)(N(C)C)Cl)C(C4=CC=CC=C4)(C5=CC=CC=C5)C6=CC=CC=C6
—